Literature DB >> 21816216

Treatment of leishmaniasis in the Oyapock basin (French Guiana): A K.A.P. survey and analysis of the evolution of phytotherapy knowledge amongst Wayãpi Indians.

Guillaume Odonne1, Franck Berger, Didier Stien, Pierre Grenand, Geneviève Bourdy.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Cutaneous leishmaniasis is a neglected disease with a high incidence in French Guiana, mainly in the middle and upper Oyapock basin, where Amerindian and some Brazilian people live. The main goals of this work were (i) to assess the knowledge about leishmaniasis in the different populations of the middle and upper Oyapock basin, (ii) to study the therapeutic strategies adopted by people affected by leishmaniasis and (iii) to document the use of phytotherapeutic remedies for leishmaniasis. Knowledge, attitudes and practices (K.A.P.) related to this disease and its treatments have been studied according to cultural group and geographical settlement. Within the Wayãpi group, the evolution of the knowledge of phytoremedies over the last 20 years has been characterised by literature-based comparisons.
MATERIALS AND METHODS: A total of 144 questionnaires were administered in all the villages of the upper Oyapock and Camopi basins. Correspondence analyses were used for multivariate analysis. Plant species were identified at the Cayenne Herbarium (CAY).
RESULTS: The biomedical concept of leishmaniasis correlates well with the Teko and Wayãpi concepts of kalasapa and kalasapau. Although the vector of this disease was not correctly identified, the most commonly cited aetiology (74.5%) was vector-borne, and related epidemiological schemes correlate well with the one encountered in French Guiana. Theoretically and practically, health centres were the most commonly used resource for diagnostic in instances of leishmaniasis infection (65.9%), independently of the patient's cultural group, along with the use of pharmaceutical drugs (85.3%). Pharmaceuticals were commonly utilised despite the frequent (51.5%) use of phytotherapeutic remedies, alone or in combination with drugs. The most cited medicinal plant species for the treatment of leishmaniasis included Eleutherine bulbosa (Mill.) Urb. (Iridaceae, cited 14 times), Euterpe oleracea Mart. (Arecaceae, 9), Cecropia obtusa Trecul (Cecropiaceae, 8), Jatropha curcas L. (Euphorbiaceae, 7), Ceiba pentandra (L.) Gaertn. (Bombacaceae, 6) and Carica papaya L. (Caricaceae, 6). Multiple correspondence analyses demonstrated that the species used in leishmaniasis remedies are more prone to vary by the user's place of residence than by their cultural origin, which indicates that exchange of knowledge about leishmaniasis remedies has occurred across different cultural groups. Literature-based comparisons between the remedies for leishmaniasis used by the Wayãpi during the 1980s showed a striking evolution, both in terms of diversity of species and number of plants used. The large number of species shared with other Guianese groups argues for intercultural exchange and may explain the majority (57.1%) of the newly used species highlighted in our study.
CONCLUSIONS: Leishmaniasis is a well-known disease in the studied area. Phytotherapeutic treatments are still in use, although they are not the main source of remedies, and should undergo pharmacological studies to evaluate their potential therapeutic value.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816216     DOI: 10.1016/j.jep.2011.07.044

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Antiplasmodial Properties and Bioassay-Guided Fractionation of Ethyl Acetate Extracts from Carica papaya Leaves.

Authors:  Paula Melariri; William Campbell; Paschal Etusim; Peter Smith
Journal:  J Parasitol Res       Date:  2011-11-17

2.  In Vivo Antiprotozoal Activity of the Chloroform Extract from Carica papaya Seeds against Amastigote Stage of Trypanosoma cruzi during Indeterminate and Chronic Phase of Infection.

Authors:  Matilde Jimenez-Coello; Karla Y Acosta-Viana; Antonio Ortega-Pacheco; Salud Perez-Gutierrez; Eugenia Guzman-Marin
Journal:  Evid Based Complement Alternat Med       Date:  2014-09-08       Impact factor: 2.629

3.  Antileishmanial Potential of Tropical Rainforest Plant Extracts.

Authors:  Lianet Monzote; Abel Piñón; William N Setzer
Journal:  Medicines (Basel)       Date:  2014-11-19

Review 4.  China-Africa cooperation initiatives in malaria control and elimination.

Authors:  Zhi-Gui Xia; Ru-Bo Wang; Duo-Quan Wang; Jun Feng; Qi Zheng; Chang-Sheng Deng; Salim Abdulla; Ya-Yi Guan; Wei Ding; Jia-Wen Yao; Ying-Jun Qian; Andrea Bosman; Robert David Newman; Tambo Ernest; Michael O'leary; Ning Xiao
Journal:  Adv Parasitol       Date:  2014       Impact factor: 3.870

Review 5.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

6.  Traditional medicines and globalization: current and future perspectives in ethnopharmacology.

Authors:  Marco Leonti; Laura Casu
Journal:  Front Pharmacol       Date:  2013-07-25       Impact factor: 5.810

7.  Palikur traditional roundwood construction in eastern French Guiana: ethnobotanical and cultural perspectives.

Authors:  Clémence Ogeron; Guillaume Odonne; Antonia Cristinoi; Julien Engel; Pierre Grenand; Jacques Beauchêne; Bruno Clair; Damien Davy
Journal:  J Ethnobiol Ethnomed       Date:  2018-04-24       Impact factor: 2.733

Review 8.  Iranian Native Plants on Treatment of Cutaneous Leishmaniosis: A Narrative Review.

Authors:  Elham Moghaddas; Ali Khamesipour; Mehdi Mohebali; Abdolmajid Fata
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

9.  Spectrum of skin diseases in Amerindian villages of the Upper Oyapock, French Guiana.

Authors:  Thomas Malmontet; Basma Guarmit; Melanie Gaillet; Celine Michaud; Nicolas Garceran; Romain Chanlin; Magalie Demar; Pierre Couppie; Romain Blaizot
Journal:  Int J Dermatol       Date:  2020-03-29       Impact factor: 2.736

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.